Eur Rev Med Pharmacol Sci 2012; 16 (8): 1045-1051 Evaluation of plasma activity level of anticoagulant proteins in patients with acute lymphoblastic leukemia in Shafa hospital Ahwaz 2010 M.T. Jalali, M. Khosravi, B. Keikhaei, F. Dehuori, M. Latifi
Eur Rev Med Pharmacol Sci 2012; 16 (6): 743-746 Eltrombopag – an oral thrombopoietin agonist V. Sharma, H. Randhawa, A. Sharma, S. Aggarwal
Eur Rev Med Pharmacol Sci 2012; 16 (5): 707-708 Non-invasive blood pressure cuff induced lower extremity wound in a diabetic patient G. Uzun 1, H. Karagoz 2, M. Mutluoglu 1, Y. Ozdemir 3, O. Uz 4, M.G. Senol 5
Eur Rev Med Pharmacol Sci 2012; 16 (5): 691-694 A mass in the posterior mediastinum; extramedullary haemopoietic tissue N.G. Baikoussis, J.P. Beis, C. Verra*, S.N. Siminelakis
Eur Rev Med Pharmacol Sci 2012; 16 (5): 672-678 Assessment of immunochemotherapy and stem cell transplantation on EBV-associated hemophagocytic lymphohistiocytosis in children: a system review and meta analysis Q. Qin 1, Z. Xie 1, Y. Shen 1, S. Yang 2, C. Liu 1, Z. Huang 1, J. Xu 1, J. Ai 1, K. Shen 3
Eur Rev Med Pharmacol Sci 2011; 15 (10): 1176-1181 No correlation exists between vitamin B12 and quality of life in healthy young adult population S.I. Alazzam 1,3, K.H. Alzoubi 1, L.T. Al-Hambouth 1, F. AlMahasneh 1, S.M. AbuRuz 2
Eur Rev Med Pharmacol Sci 2011; 15 (4): 436-445 Prevalence of anaemia in pregnant women during the last trimester: consequense for birth weight A. Demmouche, A. Lazrag, S. Moulessehoul
Eur Rev Med Pharmacol Sci 2011; 15 (1): 71-78 Influences of earthworm extract G-90 on haematological and haemostatic parameters in Wistar rats M. Matausic-Pisl 1, M. Tomicic 2, V. Micek 1, M. Grdisa 3
Eur Rev Med Pharmacol Sci 2010; 14 (10): 871-875 Prevalence of hemoglobin alpha-chain gene deletion in neonates in North of Iran M.R. Mahdavi, M. Kowsarian, H. Karami, A. Mohseni, K. Vahidshahi, P. Roshan, M.T. Hojjati, M.A. Ebrahimzadeh
Eur Rev Med Pharmacol Sci 2010; 14 (9): 785-788 Pemphigus vulgaris treated with allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning I.M. Suslova 1, D.S. Theodoropoulos 2,3, N.A.M. Cullen 3, M.K. Tetarnikova 4, A.S. Tetarnikov 5, N.A. Kolchak 1
Eur Rev Med Pharmacol Sci 2008; 12 (1): 19-31 Pathogenesis, diagnosis, and management of disseminated intravascular coagulation: Dalainas
Eur Rev Med Pharmacol Sci 2001; 5 (2): 37-42 Efficacy and safety of topical Hirudin (Hirudex®): a double-blind, placebo-controlled study P.K. Stamenova, T. Marchetti*, I. Simeonov**
Eur Rev Med Pharmacol Sci 2000; 4 (5): 111-115 Circadian rhythm of serum erythropoietin in myelodysplastic syndromes P. Pasqualetti, A. Collacciani*, R. Casale
Eur Rev Med Pharmacol Sci 2000; 4 (3): 59-66 Clinical importance of thrombomodulin serum levels F. Califano, T. Giovanniello, P. Pantone, E. Campana, C. Parlapiano, F. Alegiani*, G.M. Vincentelli*, P. Turchetti
Eur Rev Med Pharmacol Sci 1998; 2 (2): 65-74 Incidence of malignant lymphoproliferative diseases by stage and histological variants in Central Italy: a population based study 1982-1994 G. Di Leonardo, P. Torchio*, E. Pasqualoni, G. Corrao*, D. Quaglino
Eur Rev Med Pharmacol Sci 1998; 2 (2): 49-52 The lymphomas in 1998: from cell biology to therapy G. d’Onofrio, G. Zini
Eur Rev Med Pharmacol Sci 2016; 20 (9): 1680-1690 A prospective evaluation of minimal residual disease as risk stratification for CCLG-ALL-2008 treatment protocol in pediatric B precursor acute lymphoblastic leukemia Y.-X. Hu, J. Lu, H.-L. He, Y. Wang, J.-Q. Li, P.-F. Xiao, J. Li, H. Lv, Y.-N. Sun, J.-J. Fan, Y.-H. Chai, S.-Y. Hu Free PDF Download